EUVIMEDEUVIMED entdecken
Studienprotokoll

Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?

Yıldız Akdaş Reis, Arife Akay, Merve Özkan, Fahri Burçin Fıratlıgil, Murat Levent Dereli, Tuğba Kınay, Salim Erkaya

Archives of Gynecology and Obstetrics · 2023

DOI: 10.1007/s00404-023-07116-3 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Archives of Gynecology and Obstetrics, 2023. Verfasst von Yıldız Akdaş Reis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics-Gynecology Department, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, Ankara, Turkey. yildizakdasreis@ho…. Hauptthemen laut MEDLINE: Methotrexate, Chorionic Gonadotropin, beta Subunit, Human, Abortifacient Agents, Nonsteroidal, Pregnancy, Tubal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: The single-dose methotrexate (MTX) regimen is effective and minimizes side effects but an additional second dose is needed in case of failure in an ectopic pregnancy (EP). We aimed to predict the additional MTX dose by evaluating the change in β-hCG values between day 0 and day 4 in EPs with administered single-dose MTX regimen. METHOD: A total of 454 tubal EPs between 2013 and 2019 were evaluated retrospectively. Cases cured with a single dose of MTX without an additional dose were accepted as the control group, and cases under a single-dose regimen were cured by applying a second dose of MTX on the 7th day were accepted as the study group. Obstetric and demographic characteristics and the change in β-hCG values compared in both groups. RESULTS: Age, body mass index (BMI), gravida, smoking, abdominal surgery, presence of IUDs, initial β-hCG levels (0th day), and EP size were similar in both groups, but the presence of previous EP history was significantly higher in the study group. The change of β-hCG from days 0 and 4 determined that a 20% increase predicts the need for a second dose of MTX with 72.4% sensitivity, and 87.8% negative predictive value (NPV). CONCLUSION: The single-dose MTX protocol is successful in 83.3% of convenient cases (as the control group), but an increase of 20% in β-hCG between days 0 and 4 predicts the patients who need to be administered second-dose MTX, and thus, a double-dose MTX protocol will be achieved early.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateChorionic Gonadotropin, beta Subunit, HumanAbortifacient Agents, NonsteroidalPregnancy, TubalHumansFemalePregnancyAdultRetrospective Studies

Stichwörter der Autor:innen

Ectopic pregnancyMethotrexateSecond doseSingle doseΒ-hcG

Substanzen

MethotrexateChorionic Gonadotropin, beta Subunit, HumanAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Obstetrics-Gynecology Department, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, Ankara, Turkey. yildizakdasreis@hotmail.com.
  • Obstetrics-Gynecology Department, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, Ankara, Turkey.
  • Bingol maternity and children's hospital, Bingöl, Turkey.
  • Ankara Etlik City Hospital, Ankara Etlik City Hospital, Ankara, Türkiye.
  • Ankara Bilkent City Hospital, Ankara Bilkent City Hospital, Ankara, Türkiye.

Zitieren

APA

Akdaş Reis, Y., Akay, A., Özkan, M., Fıratlıgil, F. B., Dereli, M. L., Kınay, T., & Erkaya, S. (2023). Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-07116-3

Vancouver

Akdaş Reis Y, Akay A, Özkan M, Fıratlıgil FB, Dereli ML, Kınay T, et al. Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?. Archives of Gynecology and Obstetrics. 2023. doi:10.1007/s00404-023-07116-3

BibTeX
@article{AkdaReis2023,
  author = {Akdaş Reis, Yıldız and Akay, Arife and Özkan, Merve and Fıratlıgil, Fahri Burçin and Dereli, Murat Levent and Kınay, Tuğba and Erkaya, Salim},
  title = {Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2023},
  doi = {10.1007/s00404-023-07116-3}
}
Kostenlos starten →